At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02228 XTALPI
Trading 11-03 11:21:29
5.960
-0.055
-0.91%
High6.005Low5.845Vol14.57M
Open5.975D1 Closing6.015Amplitude2.66%
Mkt Cap25.61BTradable Cap25.61BTotal Shares4.30B
T/O86.40MT/O Rate0.34%Tradable Shares4.30B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Movement Alert｜XTALPI falls 5.07% in Regular Trading, trading at 5.785 HKD
Market Focus  ·  11-02 09:58
Movement Alert｜XTALPI falls 5.07% in Regular Trading, trading at 5.785 HKD
How New SiRNA Candidate Will Impact XtalPi Stock Investors
Simply Wall St.  ·  10-29
How New SiRNA Candidate Will Impact XtalPi Stock Investors
Is XtalPi Holdings (SEHK:2228) Fully Priced On Its New siRNA Candidate?
Simply Wall St.  ·  10-24
Is XtalPi Holdings (SEHK:2228) Fully Priced On Its New siRNA Candidate?
XTALPI Issues 225,000 Shares Under Share Scheme
Stock News  ·  10-23
XTALPI Issues 225,000 Shares Under Share Scheme
XTALPI cuts issued share base by 0.11% after cancelling 4.88 million repurchased shares
Bulletin Express  ·  10-22
XTALPI cuts issued share base by 0.11% after cancelling 4.88 million repurchased shares
Xtalpi Files Next-Day Disclosure Return with HKEX on Share Repurchase, Cancellation
Reuters  ·  10-22
Xtalpi Files Next-Day Disclosure Return with HKEX on Share Repurchase, Cancellation
Movement Alert｜XTALPI Falls 5.08% in Regular Trading, Innovative Drug Sector Pullback Weighs on Sentiment
Market Focus  ·  10-22
Movement Alert｜XTALPI Falls 5.08% in Regular Trading, Innovative Drug Sector Pullback Weighs on Sentiment
QuantumPharm Holdings Limited Raises Stake in XTALPI by 1 Million Shares at HK$5.9051 Each
Stock News  ·  10-21
QuantumPharm Holdings Limited Raises Stake in XTALPI by 1 Million Shares at HK$5.9051 Each
How First SiRNA Candidate Will Impact XtalPi Holdings Stock Investors
Simply Wall St.  ·  10-21
How First SiRNA Candidate Will Impact XtalPi Holdings Stock Investors
Hong Kong-Listed XtalPi Climbs as Chairman Buys Shares
Reuters  ·  10-20
Hong Kong-Listed XtalPi Climbs as Chairman Buys Shares
HK Movers | Hong Kong Innovative Drug Stocks Rise With HANSOH PHARMA Up 8%, WUXI BIO Up 5%, EVEREST MED Up 4%
Tiger Newspress  ·  10-20
HK Movers | Hong Kong Innovative Drug Stocks Rise With HANSOH PHARMA Up 8%, WUXI BIO Up 5%, EVEREST MED Up 4%
XtalPi Chairman Buys HK$25 Million More Shares
MT Newswires Live  ·  10-20
XtalPi Chairman Buys HK$25 Million More Shares
XtalPi Says Chairman Purchases 3.8 MLN Shares from Oct 7 to Oct 15
Reuters  ·  10-20
XtalPi Says Chairman Purchases 3.8 MLN Shares from Oct 7 to Oct 15
XTALPI Chairman Acquires Additional 3.79 Million Shares, Investing About HK$25.00 Million
Bulletin Express  ·  10-20
XTALPI Chairman Acquires Additional 3.79 Million Shares, Investing About HK$25.00 Million
Xtalpi - Share Purchases Represent 0.09% of Issued Shares for HK$25 Mln
THOMSON REUTERS  ·  10-20
Xtalpi - Share Purchases Represent 0.09% of Issued Shares for HK$25 Mln
Xtalpi - Chairman Purchases 3.8 Mln Shares from Oct 7 to Oct 15, 2026
THOMSON REUTERS  ·  10-20
Xtalpi - Chairman Purchases 3.8 Mln Shares from Oct 7 to Oct 15, 2026
XtalPi Nominates First siRNA Preclinical Candidate for IgA Nephropathy After Nine Months
Reuters  ·  10-15
XtalPi Nominates First siRNA Preclinical Candidate for IgA Nephropathy After Nine Months
Movement Alert｜XTALPI Falls 5.45% in Regular Trading, AI Drug Discovery Weakness Continues to Pressure the Stock
Market Focus  ·  10-15
Movement Alert｜XTALPI Falls 5.45% in Regular Trading, AI Drug Discovery Weakness Continues to Pressure the Stock
Board Chairman Wen Shuhao Increases Stake in XTALPI by 993,000 Shares at Approximately HK$6.89 Each
Stock News  ·  10-13
Board Chairman Wen Shuhao Increases Stake in XTALPI by 993,000 Shares at Approximately HK$6.89 Each
Ailux Appoints Lloyd S. Miller, M.d., Ph.d., as Chief Medical Officer
THOMSON REUTERS  ·  10-13
Ailux Appoints Lloyd S. Miller, M.d., Ph.d., as Chief Medical Officer

Introduction

Company Name.
XTALPI
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
XtalPi Holdings Ltd is a holding company primarily engaged in the provision of drug and material science research and development solutions and services in the pharmaceutical and material science industries. The Company mainly operates two businesses. Drug discovery solutions primarily encompass the development of early-stage lead compounds and investigational new drugs, providing research support for clinical trial initiation. Intelligent robotics solutions primarily include solid-state research and development services and automated chemical synthesis services. The Company conducts its business in the domestic and overseas markets.
Issue price:
--